Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q2 FY22 results · Jul–Sep 2021
Acutaas Chemicals reported revenue from operations of ₹122.31 crore and net profit of ₹17.47 crore for Q2 FY22 (Jul–Sep 2021), on a consolidated basis.
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 122.31 | — | — | — | — |
| Other income | 0.16 | — | — | — | — |
| Total income | 122.47 | — | — | — | — |
| Profit before tax | 22.52 | — | — | — | — |
| Net profit for the period | 17.47 | — | — | — | — |
| EPS, basic (₹) | 5.11 | — | — | — | — |
| Net margin (%) | 14.3 | — | — |
| Item | Q2 FY22 | Q2 FY21 | YoY | Q1 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 122.31 | — | — | — | — |
| Other income | 0.16 | — | — | — | — |
| Total income | 122.47 | — | — | — | — |
| Profit before tax | 22.52 | — | — | — | — |
| Net profit for the period | 17.47 | — | — | — | — |
| EPS, basic (₹) | 5.11 | — | — | — | — |
| Net margin (%) | 14.3 | — | — |
Consolidated
- Filed with BSE
- 25 Oct 2021, 11:04 IST
- Board meeting
- 23 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 25 Oct 2021, 11:04 IST
- Board meeting
- 23 Oct 2021
- Period
- 01 Jul 2021 to 30 Sep 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE